MR疫苗的市場規模、市場佔有率、展望、機會分析 (2021年~2028年):各疫苗品牌 (MR疫苗、MRBEV)、流通管道、地區
市場調查報告書
商品編碼
1068435

MR疫苗的市場規模、市場佔有率、展望、機會分析 (2021年~2028年):各疫苗品牌 (MR疫苗、MRBEV)、流通管道、地區

MR Vaccines Market, by Vaccine Brand (MR Vaccine and MRBEV, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

MR (麻疹、德國麻疹) 的發生率增加,MR疫苗開發的臨床試驗的進展,疫苗接種服務相關意識的高漲,為了開始疫苗宣傳活動的政府的配合措施高漲,在MR疫苗市場活動的主要企業與WHO、UNICEF、全球疫苗免疫聯盟等組織的夥伴關係等無機成長策略等要素,有望促進在預測期間內的MR疫苗市場成長。

本報告提供全球MR疫苗的市場調查,市場概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素的分析,市場規模的變化、預測,疫苗品牌、流通管道、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 調查目的、前提條件

第2章 市場範圍

第3章 市場動態、法規、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 治療評估
  • 疾病評估
  • 流行病學評估
  • 產業評估

第4章 MR疫苗市場:COVID-19影響

  • 經濟影響
  • 臨床試驗、醫藥品開發的影響
  • 政府的舉措

第5章 MR疫苗市場:各疫苗品牌

  • MR疫苗
  • MRBEV(BE LTD.)

第6章 MR疫苗市場:各流通管道

  • 公共
  • 私人

第7章 MR疫苗市場:各地區

  • 獨立國協(CIS)各國
  • 南美
  • 歐洲
  • 亞洲
  • 中東
  • 非洲

第8章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • PT Bio Farma
    • Bio-Manguinhos
    • Crucell Switzerland AG
    • Serum Institute of India
    • BE Vaccines
  • 分析師的見解

第9章 Section

簡介目錄
Product Code: CMI4917

Measles and rubella is a live virus vaccine that protects against infection with the measles and rubella viruses. It works by causing the body to produce its antiviral defenses (antibodies). Measles (also known as coughing measles, hard measles, morbilli, red measles, rubeola, and 10-day measles) is a highly contagious infectious disease. Measles infection can result in significant complications such as pneumonia, ear infections, sinus infections, convulsions (seizures), brain damage, and death. Adults and children under the age of 5 years are at a higher risk of serious complications and mortality. When pregnant women contract rubella (also known as German measles), it can result in miscarriages, stillbirths, or birth abnormalities in their unborn children.

Market Dynamics

Measles and Rubella (MR) vaccine is a subcutaneous injection for active immunization against Measles and Rubella in young adults, adolescents, children, and infants at risk. Increasing incidence of Measles and Rubella (MR), ongoing clinical trials to develop MR vaccines, growing awareness about immunization services, rising government initiatives to launch vaccine campaigns, and increasing adoption of inorganic growth strategies such partnerships by key players operating in the MR vaccines market with organizations such as WHO, UNICEF, and the GAVI Alliance are the major factors that are expected to drive growth of the MR vaccines market over the forecast period.

For instance, according to the World Health Organization (WHO), from January 2020 to April 2021, eight African nations experienced major measles outbreaks that affected tens of thousands of children, owing to delayed vaccination programs or low routine immunization coverage.

Key features of the study:

  • This report provides an in-depth analysis of the MR vaccines market, and provides market size (US$ Mn. and No. of Doses in Mn.), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the MR vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include PT Bio Farma, Bio-Manguinhos, BE Vaccines, Serum Institute of India, and Crucell Switzerland AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The MR vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the MR vaccines market

Detailed Segmentation:

  • MR Vaccines Market, By Vaccine Brand:
    • MR Vaccine
    • MRBEV (BE LTD.)
  • MR Vaccines Market, By Distribution Channel:
    • Public
    • Private
  • MR Vaccines Market, By Region:
    • Commonwealth of Independent States (CIS) Countries
      • By Vaccine Brand
      • MR Vaccine
      • MRBEV (BE LTD.)
      • By Distribution Channel
      • Public
      • Private
      • By Country
      • Russia
      • Uzbekistan
      • Kazakhstan
      • Ukraine
      • Turkmenistan
      • Belarus
      • Armenia
    • Latin America
      • By Vaccine Brand
      • MR Vaccine
      • MRBEV (BE LTD.)
      • By Distribution Channel
      • Public
      • Private
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Honduras
      • Colombia
      • Peru
      • Chile
    • Europe
      • By Vaccine Brand
      • MR Vaccine
      • MRBEV (BE LTD.)
      • By Distribution Channel
      • Public
      • Private
      • By Country
      • Turkey
    • Asia Pacific
      • By Vaccine Brand
      • MR Vaccine
      • MRBEV (BE LTD.)
      • By Distribution Channel
      • Public
      • Private
      • By Country
      • Pakistan
      • Indonesia
      • Bangladesh
      • Philippines
      • Vietnam
      • Thailand
      • Myanmar
      • Malaysia
      • Cambodia
      • Nepal
      • Sri Lanka
      • Papua New Guinea
      • Mauritius
    • Middle East
      • By Vaccine Brand
      • MR Vaccine
      • MRBEV (BE LTD.)
      • By Distribution Channel
      • Public
      • Private
      • By Country
      • UAE
      • Israel
      • Iraq
      • Iran
      • Saudi Arabia
      • Jordan
      • Qatar
      • Oman
      • Syrian Arab Republic
    • Africa
      • By Vaccine Brand
      • MR Vaccine
      • MRBEV (BE LTD.)
      • By Distribution Channel
      • Public
      • Private
      • By Country/Region
      • Nigeria
      • Tanzania
      • Democratic Republic of Congo
      • Ethiopia
      • Kenya
      • South Africa
      • Egypt
      • Morocco
      • Ghana
      • Uganda
      • Burkina Faso
      • Angola
      • Algeria
      • Zimbabwe
      • Tunisia
      • Botswana
      • Libya
      • Namibia
  • Company Profiles
    • PT Bio Farma*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Bio-Manguinhos
    • BE Vaccines
    • Serum Institute of India
    • Crucell Switzerland AG

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Vaccine Brand
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Therapy Assessment
  • Disease Assessment
  • Epidemiological Assessment
  • Industry Assessment

4. MR Vaccines Market- Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • Impact on Clinical Trials and Drug Development
  • Government Initiatives

5. MR Vaccines Market, By Vaccine Brand, 2021 - 2028, (US$ Mn. and No. of Doses in Mn.)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • MR Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
  • MRBEV (BE LTD.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)

6. MR Vaccines Market, By Distribution Channel, 2021 - 2028, (US$ Mn. and No. of Doses in Mn.)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)

7. MR Vaccines Market, By Region, 2021 - 2028, (US$ Mn. and No. of Doses in Mn.)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2028
  • Commonwealth of Independent States (CIS) Countries
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Russia
    • Uzbekistan
    • Kazakhstan
    • Ukraine
    • Turkmenistan
    • Belarus
    • Armenia
  • Latin America
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Brazil
    • Mexico
    • Argentina
    • Honduras
    • Colombia
    • Peru
    • Chile
  • Europe
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Turkey
  • Asia
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Pakistan
    • Indonesia
    • Bangladesh
    • Philippines
    • Vietnam
    • Thailand
    • Myanmar
    • Malaysia
    • Cambodia
    • Nepal
    • Sri Lanka
    • Papua New Guinea
    • Mauritius
  • Middle East
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • UAE
    • Israel
    • Iraq
    • Iran
    • Saudi Arabia
    • Jordan
    • Qatar
    • Oman
    • Syrian Arab Republic
  • Africa
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Market Size and Forecast, By Region/Country, 2017 - 2028, (US$ Mn. and No. of Doses in Mn.)
    • Nigeria
    • Tanzania
    • Democratic Republic of Congo
    • Ethiopia
    • Kenya
    • South Africa
    • Egypt
    • Morocco
    • Ghana
    • Uganda
    • Burkina Faso
    • Angola
    • Algeria
    • Zimbabwe
    • Tunisia
    • Botswana
    • Libya
    • Namibia

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • PT Bio Farma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bio-Manguinhos
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Crucell Switzerland AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Serum Institute of India
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BE Vaccines
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact